2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Top Cited Papers
- 1 January 2016
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 26 (1), 1-133
- https://doi.org/10.1089/thy.2015.0020
Abstract
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the American Thyroid Association's (ATA's) guidelines for the management of these disorders were revised in 2009, significant scientific advances have occurred in the field. The aim of these guidelines is to inform clinicians, patients, researchers, and health policy makers on published evidence relating to the diagnosis and management of thyroid nodules and differentiated thyroid cancer. Methods: The specific clinical questions addressed in these guidelines were based on prior versions of the guidelines, stakeholder input, and input of task force members. Task force panel members were educated on knowledge synthesis methods, including electronic database searching, review and selection of relevant citations, and critical appraisal of selected studies. Published English language articles on adults were eligible for inclusion. The American College of Physicians Guideline Grading System was used for critical appraisal of evidence and grading strength of recommendations for therapeutic interventions. We developed a similarly formatted system to appraise the quality of such studies and resultant recommendations. The guideline panel had complete editorial independence from the ATA. Competing interests of guideline task force members were regularly updated, managed, and communicated to the ATA and task force members. Results: The revised guidelines for the management of thyroid nodules include recommendations regarding initial evaluation, clinical and ultrasound criteria for fine-needle aspiration biopsy, interpretation of fine-needle aspiration biopsy results, use of molecular markers, and management of benign thyroid nodules. Recommendations regarding the initial management of thyroid cancer include those relating to screening for thyroid cancer, staging and risk assessment, surgical management, radioiodine remnant ablation and therapy, and thyrotropin suppression therapy using levothyroxine. Recommendations related to long-term management of differentiated thyroid cancer include those related to surveillance for recurrent disease using imaging and serum thyroglobulin, thyroid hormone therapy, management of recurrent and metastatic disease, consideration for clinical trials and targeted therapy, as well as directions for future research. Conclusions: We have developed evidence-based recommendations to inform clinical decision-making in the management of thyroid nodules and differentiated thyroid cancer. They represent, in our opinion, contemporary optimal care for patients with these disorders.This publication has 1057 references indexed in Scilit:
- ENDOCRINE TUMOURS: Approach to the patient with advanced differentiated thyroid cancerActa Endocrinologica, 2012
- A combined molecular‐pathologic score improves risk stratification of thyroid papillary microcarcinomaCancer, 2011
- Use of Radioactive Iodine for Thyroid CancerJAMA, 2011
- Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapyCancer, 2011
- Molecular Testing for Somatic Mutations Improves the Accuracy of Thyroid Fine‐needle Aspiration BiopsyWorld Journal of Surgery, 2010
- Exclusion of Malignancy in Thyroid Nodules with Indeterminate Fine‐Needle Aspiration Cytology After Negative 18F‐Fluorodeoxyglucose Positron Emission Tomography: Interim AnalysisWorld Journal of Surgery, 2010
- Percutaneous radiofrequency ablation of painful osseous metastasesCancer, 2009
- Accuracy of Fine-Needle Aspiration Biopsy for Predicting Neoplasm or Carcinoma in Thyroid Nodules 4 cm or LargerArchives of Surgery, 2009
- The diagnostic value of 124I-PET in patients with differentiated thyroid cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- A 64-Year-Old Woman With a Thyroid NoduleJAMA, 2004